companyname: Molbio Diagnostics Limited ticker: MOLBIO sector: In-vitro diagnostics / point-of-care molecular diagnostics documenttype: IPO Research Report The offer has two parts. A fresh issue of up to ₹2,000 million, which is the only money the company receives. And an offer for sale of up to 9,166,000 equity shares (face value ₹1 each) by 17 selling shareholders, the proceeds of which go entirely to them. The company gets nothing from the offer for sale. | Selling shareholder | Relationshi...
Read the full report →Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Molbio Diagnostics and 4,900+ companies.
5-day free pass. No card required.